GLASDEGIB | GLASDEGIB | ATC L01XJ03
ANTINEOPLASTIC INHIBITOR OF THE HEDGEHOG PATHWAY INHIBITS SMOOTHENED TRANSMEMBRANE PROTEIN (SMO) TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) | ORAL | Cmax 3.3 MICROMOLAR Tmax 1.55 HOUR F 77 PERCENT VD 188 LITER PPB 91 PERCENT Cl 6.45 LITER / HOUR HT 17.4 HOUR SOLUBILITY SOLUBLE IN WATER (1.7 MILLIGRAM PER MILLIMITER) | SMOOTHENED (SMO) | Smoothened homolog UNIPROT Q99835 SMO more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |